Aminoglycoside use in intensive care units and aminoglycoside nephrotoxicity

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 6, 2010, Pages 2750-

  Pogue, Jason M ^a   Potoski, Brian A ^b   Kaye, Keith S ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; GENTAMICIN; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; DRUG SAFETY; DRUG USE; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; KIDNEY INJURY; LETTER; NEPHROTOXICITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ACUTE KIDNEY FAILURE; DRUG EFFECT; KIDNEY; NOTE; CONTROL GROUP; GLOMERULUS FILTRATION RATE;

AMIKACIN; AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; GENTAMICINS; HUMANS; INTENSIVE CARE UNITS; KIDNEY; KIDNEY FAILURE, ACUTE; RISK FACTORS;

EID: 77952664243     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00892-09     Document Type: Letter

References (6)

1. Beardsley, J. R., J. C. Williamson, J. W. Johnson, C. A. Ohl, T. B. Karchmer, and D. L. Bowton. 2006. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. Chest 130:787-793.
2. Bhat, S., S. Fujitani, B. A. Potoski, B. Capitano, P. K. Linden, K. Shutt, and D. L. Paterson. 2007. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved? Int. J. Antimicrob. Agents 30:458-462.
3. Drusano, G. L., P. G. Ambrose, S. M. Bhavnani, J. S. Bertino, A. N. Nafziger, and A. Louie. 2007. Back to the future: using aminoglycosides again and how to dose them optimally. Clin. Infect. Dis. 45:753-760.
4. Kaye, K. S., J. J. Engemann, E. Mozaffari, and Y. Carmelli. 2004. Reference group choice and antibiotic resistance outcomes. Emerg. Infect. Dis. 10:1125-1128.
5. Nicolau, D. P., C. D. Freeman, P. B. Belliveau, C. H. Nightingale, J. W. Ross, and R. Quintiliani. 1995. Experience with a once-daily aminoglycoside program administered to 2,184 adult patients. Antimicrob. Agents Chemother. 39:650-655.
6. Oliveira, J. F. P., C. A. Silva, C. D. Barbieri, G. M. Oliveira, D. M. T. Zanetta, and E. A. Burdmann. 2009. Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units. Antimicrob. Agents Chemother. 53:2887-2891.